Literature DB >> 8662805

Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation.

K A Palmiter1, Y Kitada, M Muthuchamy, D F Wieczorek, R J Solaro.   

Abstract

Despite its potential as a key determinant of the functional state of striated muscle, the impact of tropomyosin (Tm) isoform switching on mammalian myofilament activation and regulation in the intact lattice remains unclear. Using a transgenic approach to specifically exchange beta-Tm for the native alpha-Tm in mouse hearts, we have been able to uncover novel functions of Tm isoform switching in the heart. The myofilaments containing beta-Tm demonstrated an increase in the activation of the thin filament by strongly bound cross-bridges, an increase in Ca2+ sensitivity of steady state force, and a decrease in the rightward shift of the Ca2+-force relation induced by cAMP-dependent phosphorylation. Our results are the first to demonstrate the specific effects of Tm isoform switching on mammalian thin filament activation in the intact lattice and suggest an important role for Tm in modulation of myofilament activity by phosphorylation of troponin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662805     DOI: 10.1074/jbc.271.20.11611

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Tropomyosin modulates pH dependence of isometric tension.

Authors:  H Fujita; S Ishiwata
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

2.  Elementary steps of the cross-bridge cycle in bovine myocardium with and without regulatory proteins.

Authors:  Hideaki Fujita; Daisuke Sasaki; Shin'ichi Ishiwata; Masataka Kawai
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

3.  Tropomyosin isoforms and reagents.

Authors:  Galina Schevzov; Shane P Whittaker; Thomas Fath; Jim Jc Lin; Peter W Gunning
Journal:  Bioarchitecture       Date:  2011-07-01

4.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Authors:  M A Sussman; S Welch; N Gude; P R Khoury; S R Daniels; D Kirkpatrick; R A Walsh; R L Price; H W Lim; J D Molkentin
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 5.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

6.  Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy.

Authors:  Chad M Warren; Grace M Arteaga; Sudarsan Rajan; Rafeeq P H Ahmed; David F Wieczorek; R John Solaro
Journal:  Proteomics       Date:  2008-01       Impact factor: 3.984

7.  Instability in the central region of tropomyosin modulates the function of its overlapping ends.

Authors:  Ranganath Mamidi; Mariappan Muthuchamy; Murali Chandra
Journal:  Biophys J       Date:  2013-11-05       Impact factor: 4.033

8.  Charged residue alterations in the inner-core domain and carboxy-terminus of alpha-tropomyosin differentially affect mouse cardiac muscle contractility.

Authors:  Robert D Gaffin; Carl W Tong; David C Zawieja; Timothy E Hewett; Raisa Klevitsky; Jeffrey Robbins; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

9.  Phosphorylation of tropomyosin extends cooperative binding of myosin beyond a single regulatory unit.

Authors:  Vijay S Rao; Ellisha N Marongelli; William H Guilford
Journal:  Cell Motil Cytoskeleton       Date:  2009-01

Review 10.  Investigations into tropomyosin function using mouse models.

Authors:  Ganapathy Jagatheesan; Sudarsan Rajan; David F Wieczorek
Journal:  J Mol Cell Cardiol       Date:  2009-10-14       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.